X chromosome and suicide

Molecular Psychiatry

Volumn 16, Issue 2, 2011, Pages 216-226

  Fiori, L M ^a   Zouk, H ^a   Himmelman, C ^a   Turecki, G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

association study; depressive disorders; gender; gene expression; suicide; X chromosome

Indexed keywords

ACYLTRANSFERASE; ADAPTOR PROTEIN; GLYCOPROTEIN; PROTEIN ADAPTOR RELATED PROTEIN COMPLEX 1 SIGMA 2 SUBUNIT; PROTEIN M 6 B; PROTEIN S6; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SPERMIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; GENE EXPRESSION; GENE MAPPING; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE; X CHROMOSOME;

ACETYLTRANSFERASES; ADAPTOR PROTEIN COMPLEX SIGMA SUBUNITS; ADULT; BRAIN; CANADA; CHI-SQUARE DISTRIBUTION; CHROMOSOME MAPPING; DEPRESSION; GENE EXPRESSION PROFILING; GENES, X-LINKED; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GTPASE-ACTIVATING PROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SUICIDE;

EID: 79151474528     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.132     Document Type: Article

References (70)

1. World Health Organization. World Health Report 2000. Health Systems: Improving Performance. World Health Organization: Geneva, 2000.
2. Brent DA, Mann JJ. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005; 133: 13-24.
3. Voracek M, Loibl LM. Genetics of suicide: a systematic review of twin studies. Wien Klin Wochenschr 2007; 119: 463-475.
4. Schulsinger F, Kety SS, Rosenthal D, Wender PH. A family study of suicide. In: Schou M, Stromgren E (eds). Origin, Prevention and Treatment of Affective Disorders. Academic Press: London, UK, 1979, pp 277-287.
5. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, LunDe I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 1986; 43: 923-929.
6. Hesselbrock V, Dick D, Hesselbrock M, Foroud T, Schuckit M, Edenberg H et al. The search for genetic risk factors associated with suicidal behavior. Alcohol Clin Exp Res 2004; 28: 70S-76S.
7. Zubenko GS, Maher BS, Hughes III HB, Zubenko WN, Scott SJ, Marazita ML. Genome-wiDe linkage survey for genetic loci that affect the risk of suiciDe attempts in families with recurrent, earlyonset, major depression. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 47-54.
8. Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R et al. Genome-wiDe linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 2006; 11: 252-260.
9. Hawton K. Sex and suicide. Gender differences in suicidal behaviour. Br J Psychiatry 2000; 177: 484-485.
10. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in .3275. suicides: a meta-analysis. BMC Psychiatry 2004; 4: 37.
11. Schneider B, Wetterling T, Sargk D, Schneider F, Schnabel A, Maurer K et al. Axis I disorders and personality disorders as risk factors for suicide. Eur Arch Psychiatry Clin Neurosci 2006; 256: 17-27.
12. McGirr A, Seguin M, Renaud J, Benkelfat C, Alda M, Turecki G. Gender and risk factors for suicide: evidence for heterogeneity in predisposing mechanisms in a psychological autopsy study. J Clin Psychiatry 2006; 67: 1612-1617.
13. Oquendo MA, Bongiovi-Garcia ME, Galfalvy H, Goldberg PH, Grunebaum MF, Burke AK et al. Sex differences in clinical predictors of suicidal acts after major depression: a prospective study. Am J Psychiatry 2007; 164: 134-141.
14. Kia-Keating BM, Glatt SJ, Tsuang MT. Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 1048-1053.
15. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K. Association between catechol-O-methyltransferase functional polymorphism and male suiciDe completers. Neuropsychopharmacology 2004; 29: 1374-1377.
16. Baca-Garcia E, Vaquero C, Diaz-Sastre C, Saiz-Ruiz J, Fernandez-Piqueras J, De Leon J. A gender-specific association between the serotonin transporter gene and suiciDe attempts. Neuropsychopharmacology 2002; 26: 692-695.
17. Shindo S, Yoshioka N. Polymorphisms of the cholecystokinin gene promoter region in suiciDe victims in Japan. Forensic Sci Int 2005; 150: 85-90.
18. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD. High activity-related allele of MAO-A gene associated with depressed suiciDe in males. Neuroreport 2002; 13: 1195-1198.
19. Brunner HG, Nelen M, Breakefield XO, Ropers HH, Van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578-580.
20. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851-854.
21. Brais B, Xie YG, Sanson M, Morgan K, Weissenbach J, Korczyn AD et al. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. Hum Mol Genet 1995; 4: 429-434.
22. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998; 18: 164-167.
23. Kibar Z, Der KV, Brais B, Hani V, Fraser FC, Rouleau GA. The gene responsible for Clouston hidrotic ectodermal dysplasia maps to the pericentromeric region of chromosome 13q. Hum Mol Genet 1996; 5: 543-547.
24. First MB, Gibbon M, Spitzer RL. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/P). Biometrics Research Department, New York State Psychiatric Institute: New York, NY, 2001.
25. C-DIS Management Group. Computerized Diagnostic Interview Schedule (Revised) DSM-III-R. C-DIS Management Group: Ottawa, Ontario, Canada, 1991.
26. Hercher C, Turecki G, Mechawar N. Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res 2009; 43: 947-961.
27. Bird ED, Vonsattel JP. The development of a brain bank. J Neural Transm Suppl 1993; 39: 17-23.
28. Nolte J. The Human Brain: An Introduction to its Functional Neuroanatomy. Mosby Inc.: St Louis, MO, 2002.
29. Kim C, Lesage A, Seguin M, Chawky N, Vanier C, Lipp O et al. Patterns of co-morbidity in male suiciDe completers. Psychol Med 2003; 33: 1299-1309.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press: Plainview, New York, 1989.
31. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
32. Abecasis GR, Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.
33. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero Jr RA et al. Implication of SSAT by gene expression and genetic variation in suiciDe and major depression. Arch Gen Psychiatry 2006; 63: 35-48.
34. Klempan TA, Rujescu D, Merette C, Himmelman C, Sequeira A, Canetti L et al. Profiling brain expression of the spermidine/ spermine N(1)- acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 934-943.
35. Stine OC, McMahon FJ, Chen L, Xu J, Meyers DA, MacKinnon DF et al. Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet 1997; 74: 263-269.
36. Ekholm JM, Pekkarinen P, Pajukanta P, Kieseppa T, Partonen T, Paunio T et al. Bipolar disorder susceptibility region on Xq24-q27.1 in Finnish families. Mol Psychiatry 2002; 7: 453-459.
37. Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D et al. A genomewiDe screen for autism susceptibility loci. Am J Hum Genet 2001; 69: 327-340.
38. Hallmayer J, Hebert JM, Spiker D, Lotspeich L, McMahon WM, Petersen PB et al. Autism and the X chromosome. Multipoint sibpair analysis. Arch Gen Psychiatry 1996; 53: 985-989.
39. Gécz J, Barnett S, Liu J, Hollway G, Donnelly A, Eyre H et al. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 1999; 62: 356-368.
40. O'Connor JA, Muly EC, Arnold SE, Hemby SE. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr Res 2007; 90: 28-40.
41. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 2007; 164: 1530-1538.
42. Magri C, Gardella R, Valsecchi P, Barlati SD, Guizzetti L, Imperadori L et al. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 745-753.
43. Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007; 12: 640-655.
44. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, Ffrench-Mullen J et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009; 14: 175-189.
45. Fiori LM, Turecki G. Implication of the polyamine system in mental disorders. J Psychiatry Neurosci 2008; 33: 102-110.
46. Zeniou M, Ding T, Trivier E, Hanauer A. Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum Mol Genet 2002; 11: 2929-2940.
47. Wang Y, Martinez JE, Wilson GL, He XY, Tuck-Muller CM, Maertens P et al. A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome. Am J Med Genet A 2006; 140: 1274-1279.
48. Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J et al. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet 1999; 22: 13-14.
49. Field M, Tarpey P, Boyle J, Edkins S, Goodship J, Luo Y et al. Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation. Clin Genet 2006; 70: 509-515. (Pubitemid 44741473)
50. Delaunoy JP, Dubos A, Marques PP, Hanauer A. Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Clin Genet 2006; 70: 161-166.
51. Madrigal I, Rodriguez-Revenga L, Badenas C, Sanchez A, Martinez F, Fernandez I et al. MLPA as first screening method for the detection of microduplications and microdeletions in patients with X-linked mental retardation. Genet Med 2007; 9: 117-122.
52. Tarpey PS, Stevens C, Teague J, Edkins S, O'Meara S, Avis T et al. Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am J Hum Genet 2006; 79: 1119-1124.
53. Saillour Y, Zanni G, Des PV, Heron D, Guibaud L, Iba-Zizen MT et al. Mutations in the AP1S2 gene encoding the sigma 2 subunit of the adaptor protein 1 complex are associated with syndromic X-linked mental retardation with hydrocephalus and calcifications in basal ganglia. J Med Genet 2007; 44: 739-744.
54. Borck G, Molla-Herman A, Boddaert N, Encha-Razavi F, Philippe A, Robel L et al. Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome. Hum Mutat 2008; 29: 966-974.
55. Tondreau T, Dejeneffe M, Meuleman N, Stamatopoulos B, Delforge A, Martiat P et al. Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics 2008; 9: 166.
56. Yan Y, Lagenaur C, Narayanan V. Molecular cloning of M6: identification of a PLP/DM20 gene family. Neuron 1993; 11: 423-431.
57. Yan Y, Narayanan V, Lagenaur C. Expression of members of the proteolipid protein gene family in the developing murine central nervous system. J Comp Neurol 1996; 370: 465-478.
58. Werner H, Dimou L, Klugmann M, Pfeiffer S, Nave KA. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Mol Cell Neurosci 2001; 18: 593-605.
59. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434: 400-404.
60. Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Ruiz NP. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med 2008; 86: 61-74.
61. Talebizadeh Z, Simon SD, Butler MG. X chromosome gene expression in human tissues: male and female comparisons. Genomics 2006; 88: 675-681.
62. Skuse DH. X-linked genes and mental functioning. Hum Mol Genet 2005; 14(Spec No 1): R27-R32.
63. Hebebrand J, Hennighausen K. A critical analysis of data presented in eight studies favouring X-linkage of bipolar illness with special emphasis on formal genetic aspects. Hum Genet 1992; 90: 289-293.
64. Zandi PP, Willour VL, Huo Y, Chellis J, Potash JB, MacKinnon DF et al. Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet B Neuropsychiatr Genet 2003; 119: 69-76.
65. DeLisi LE, Devoto M, Lofthouse R, Poulter M, Smith A, Shields G et al. Search for linkage to schizophrenia on the X and Y chromosomes. Am J Med Genet 1994; 54: 113-121.
66. Laval SH, Dann JC, Butler RJ, Loftus J, Rue J, Leask SJ et al. Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome. Am J Med Genet 1998; 81: 420-427.
67. Zubenko GS, Maher B, Hughes III HB, Zubenko WN, Stiffler JS, Kaplan BB et al. Genome-wiDe linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet 2003; 123: 1-18.
68. Gauthier J, Joober R, Dube MP, St Onge J, Bonnel A, Gariepy D et al. Autism spectrum disorders associated with X chromosome markers in French-Canadian males. Mol Psychiatry 2006; 11: 206-213.
69. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29.
70. Simard LR, Prescott G, Rochette C, Morgan K, Lemieux B, Mathieu J et al. Linkage disequilibrium analysis of childhood-onset spinal muscular atrophy (SMA) in the French-Canadian population. Hum Mol Genet 1994; 3: 459-463.